Ononin Shows Anticancer Activity Against Laryngeal Cancer via the Inhibition of ERK/JNK/p38 Signaling Pathway

BACKGROUND: Laryngeal cancer is a type of head and neck tumor with a poor prognosis and survival rate. The new cases of laryngeal cancer increased rapidly with a higher mortality rate around the world. OBJECTIVE: The current research work was focused to unveil the in vitro antitumor effects of ononi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Ben, Ma, Jianhua, Li, Zhaoxia, Li, Yang, Han, Xiaopan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334013/
https://www.ncbi.nlm.nih.gov/pubmed/35912256
http://dx.doi.org/10.3389/fonc.2022.939646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334013/
https://www.ncbi.nlm.nih.gov/pubmed/35912256
http://dx.doi.org/10.3389/fonc.2022.939646

Ejemplares similares